Skip to main content

Fiscal Wizard · Single-issue tearsheet

SER / Jun 21, 2026 Run #7502

SER

Serina Therapeutics, Inc.

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is headquartered in Huntsville, Alabama.

Composite verdict

F 8.0 / 100
Bearish setup · Oscillator 7 drivers · 6 gates blocking
  • Williams %R
  • Commodity Channel Index
  • Bollinger Mean Reversion
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 472nd of 598 in Biotechnology

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 11 signals100% Bear
Momentum Neutral 50Mean-reversion Bearish 1

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

15.4 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Revenue Growth (YoY) 100
Return on Capital Employed 0
Gross Margin 75
Return on Assets 0
P/B 75
Greenblatt ROC 0

Technicals Bearish

0.7 / 100

Bearish setup leads (Williams %R, Commodity Channel Index, Bollinger Mean Reversion); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 5
Commodity Channel Index 14
Bollinger Mean Reversion 16

Risk Gates

6 blocking 3 caution

6 guards active, 31 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Debt-to-Assets Blocking

High debt-to-assets blocks bullish signals — balance-sheet leverage risk.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for SER.